2026. Detection and Assessment of Drug-Related Problems Associated with Dapagliflozin in Patients with Type 2 Diabetes Mellitus: A Retrospective Cross-Sectional Study. International Journal of Pharmacetical Sciences Letters. 16, 1 (Feb. 2026), 01–04.